ARDX
NASDAQ · Biotechnology
Ardelyx Inc
$3.48
-0.14 (-3.87%)
Open$3.60
Previous Close$3.62
Day High$3.62
Day Low$3.42
52W High$8.40
52W Low$3.34
Volume—
Avg Volume4.27M
Market Cap836.02M
P/E Ratio—
EPS$-0.23
SectorBiotechnology
Analyst Ratings
Strong Buy
18 analysts
Price Target
+1,254.6% upside
Current
$3.48
$3.48
Target
$47.14
$47.14
$33.22
$47.14 avg
$55.45
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 416.75M | 210.06M | 556.78M |
| Net Income | -63,034,756 | -28,594,395 | -22,621,785 |
| Profit Margin | -15.1% | -14.4% | -4.1% |
| EBITDA | -38,792,516 | -18,575,045 | -31,484,723 |
| Free Cash Flow | — | — | -21,445,059 |
| Rev Growth | +98.4% | +98.4% | +16.2% |
| Debt/Equity | 1.21 | 1.21 | 0.37 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.08 | -0.05% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $406.09 | -1.01% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $151.37 | -0.85% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $516.34 | +0.26% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $801.82 | -0.26% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $246.51 | -2.04% | 40.0 | 32.33B |